Anteris Technologies (ASX:AVR) Update on Schemes, Nasdaq listing and US IPO

Anteris Technologies Ltd (ASX:AVR) has extended the timetable for the planned re-domiciliation to the United States and the listing on Nasdaq. The Scheme meetings and EGM on 4 October 2024 have been deferred to accommodate changes to the timetable. The US IPO process continues to progress, and the Company intends to expand participation in the Scheme with new eligible countries.

Anteris Technologies (ASX:AVR) Executive Commentary

The Company continues to progress towards the US IPO, and the original timetable has been extended due to the complexity of the cross-border transaction and capital raising. The ATL board unanimously recommends shareholders vote in favor of the Share Scheme, and ATL optionholders vote in favor of the Option Scheme. This announcement is not an offer to participate in the US IPO, and the Company cannot guarantee the successful completion of the US IPO.

Anteris Technologies (ASX:AVR) Summary

Anteris Technologies Ltd (ASX:AVR) has extended the timetable for the planned re-domiciliation to the United States and the listing on Nasdaq. The Company intends to hold the Scheme Meetings and EGM in October or November this year. The ATL board maintains the advantages of the Re-domiciliation significantly outweigh the disadvantages and risks. The Company is seeking to expand the eligible countries for participation in the Scheme and will provide further details when available.